TOPAbout TaihoConsolidated Financial Statements

Consolidated Financial Statements

Consolidated Balance Sheets

Taiho Pharmaceutical Co., Ltd. As of March 31, 2011 and March 31, 2010

ASSETS Millions of yen Thousands of
U.S. Dollars
2010 2009 2010
Current assets
Cash on hand and in banks¥116,242¥128,225$1,400,506
Trade notes and accounts receivable48,53944,527584,809
Marketable securities33,39424,144402,343
Inventories15,13214,624182,320
Short-term loans receivable from subsidiaries and affiliates10,00010,000120,481
Deferred income taxes2,1492,23325,895
Other current assets15,3812,996185,319
Total current assets240,839226,7532,901,676
Property, plant and equipment - Less accumulated
Buildings and structures11,56912,160139,394
Machinery and equipment, and Vehicles3,1173,58337,560
Land17,007 17,100204,914
Construction in progress267843,217
Other4,296 4,78951,770
Total property, plant and equipment, net36,25937,719436,857
Intangible assets4,3982,67352,992
Investments and other assets
Investment securities56,80164,033684,358
Deferred income taxes4,8524,34558,467
Other investments and other assets11,79011,153142,052
Allowance for doubtful accounts(58)(58)(708)
Total investments and other assets73,38679,473884,168
Total assets354,882346,6194,275,694
LIABILITIES AND SHAREHOLDERS’ EQUITYMillions of yenThousands of
U.S. dollars
2010 20092010
Current liabilities
Trade notes and accounts payable7,2426,17187,255
Other accounts payable7,6976,78892,735
Accrued income taxes3,1622,26038,097
Other current liabilities7,4609,07689,886
Capital expenditures25,56124,297307,974
Fixed liabilities
Accrued pension liabilities8,6908,195104,701
Other long-term liabilities1,2971,10715,629
Total fixed liabilities9,9879,303120,330
Shareholders' equity
Common stock,without par value
Authorized: 800,000 shares, Issued: 400,000 shares
2002002,409
Capital surplus1515180
Retained earnings318,046311,4183,831,890
Unrealized holding gains on securities1,0711,38512,907
Total shareholders' equity319,333313,0193,847,389
Total liabilities and shareholders' equity354,882346,6194,275,694

Notes:
1)Amounts have been rounded down to millions of yen or thousands of U.S. dollars.
2)Accumulated depreciation of property, plant and equipment: ¥64,672million.
3)In addition to fixed assets of the balance sheets, leased equipment, including computers used in the Company's operations, is treated as a principal fixed asset. In fiscal 2010, lease payments totaled ¥44million.
4)U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥83=US$1, the approximate exchange rate at March 31,2011.

Consolidated Statements of Income and Retained Earnings

Taiho Pharmaceutical Co., Ltd. and Consolidated Subsidiaries
Fiscal years ended March 31, 2010 and June 30, 2009

ASSETS Millions of yen Thousands of
U.S. Dollars
2010 2009 2010
Net sales¥123,581¥120,716$1,488,934
Cost of sales32,523 31,163 391,847
Gross profit91,058 89,552 1,097,087
Selling, general and administrative expenses75,279 74,988 906,986
Operating income15,778 14,564 190,100
Other income (expenses)
Interest and dividends income1,030 1,101 12,417
Interest expense(0)(0)(6)
Other1,209 571 14,577
2,240 1,671 26,989
Income before income taxes18,018 16,236 217,089
Income taxes
Current6,056 6,017 72,966
Deferred(165)(245)(1,997)
5,890 5,771 70,969
Net income12,127 10,464 146,120
Retained earnings
Opening balance311,418 304,954 3,752,035
Additions
Net income12,127 10,464 146,120
Deductions
Cash dividends paid(5,500)(4,000)(66,265)
Balance at end of the year318,046 311,418 3,831,890

Notes:
1)Amounts have been rounded down to millions of yen or thousands of U.S. dollars.
2)U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥83=US$1, the approximate exchange rate at March 31,2011

yen U.S. dollars
Amounts per share of common stock
Net income¥30,319.91¥26,161.75$365.30
Cash dividends applicable to the year15,00013,750180.72

Notes:
U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥83=US$1, the approximate exchange rate at March 31,2011


Top of Page